This inventor holds 8 USPTO granted patents. Top assignees: G.d. Searle & Company, The Government of the United States of America, as Represented by the, The United States of America as Represented by the Department of Health. Active years: 1989-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1989-1997
Title: The Innovative Contributions of George R. Martin
Introduction
George R. Martin is a notable inventor based in Bethesda, MD, with a remarkable portfolio of eight patents. His work primarily focuses on advancements in biomedical applications, particularly in the field of collagen fibers and angiogenesis.
Latest Patents
Among his latest patents, Martin has developed a method for controlling the structural stability of collagen fibers. This invention provides stabilized dispersions of collagen fibers that have been treated to inactivate infectious agents. Additionally, he has created a method for performing in vivo angiogenesis assays. This method utilizes a matrix material that remains in an injectable solution form at lower temperatures and forms a gel matrix upon injection into a host. The matrix can be enhanced with angiogenic factors, allowing for the quantification of angiogenesis after recovery.
Career Highlights
Throughout his career, Martin has made significant contributions to the field of biomedical research. His innovative approaches have led to advancements that could potentially improve therapeutic strategies in various medical applications.
Collaborations
Martin has collaborated with esteemed colleagues such as Hynda K. Kleinman and Yoshihiko Yamada, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
George R. Martin's contributions to the field of biomedical innovation are noteworthy, showcasing his dedication to advancing medical science through his patents and collaborative efforts. His work continues to influence the development of new therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile